Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Laura Armas, Creighton University
ClinicalTrials.gov Identifier:
NCT01592539
First received: May 3, 2012
Last updated: May 15, 2013
Last verified: May 2013

May 3, 2012
May 15, 2013
May 2012
October 2013   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01592539 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

The effects of high serum glucose on bone could be direct or could be indirect through its effects on the microvasculature. Previous studies by Rendell et al and Brugler et al have found significant differences in skin blood flow between diabetics and control. The investigators are proposing that blood flow measurements of the skin may be correlated with bone remodeling rates in iliac bone biopsies.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Patients with Type 1 DM

  • Type 1 Diabetes,
  • Bone
Not Provided
  • Case
    Patients with Type 1 Diabetes Mellitus
  • Control
    Age and sex matched healthy controls.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
60
October 2013
October 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Must have completed a previous study.
Both
19 Years to 50 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01592539
Creighton11
No
Laura Armas, Creighton University
Creighton University
Not Provided
Principal Investigator: Laura AG Armas, MD Creighton University
Creighton University
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP